Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
Crossref DOI link: https://doi.org/10.1007/s40271-014-0108-6
Published Online: 2015-01-06
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Menon, Devidas
Stafinski, Tania
Dunn, Andrea
Wong-Rieger, Durhane
License valid from 2015-01-06